Uniqure NVQURE
± MixedCapitalrelevance
Earnings preview with consensus estimates and revision trends, but no actual results yet.
Impact on stocks 1
Biotech & Genomic Medicine
Uniqure NVuniQure is scheduled to announce its second-quarter earnings results on Wednesday, July 29th, before the market opens. The consensus earnings per share estimate stands at -$0.81, while the consensus revenue estimate is $5.38 million, representing a 2.3% increase year-over-year. Over the last three months, EPS estimates have seen seven upward revisions and two downward revisions, whereas revenue estimates have seen three upward revisions and seven downward revisions.
Uniqure NVEarnings preview with consensus estimates and revision trends, but no actual results yet.